When Kåre Schultz joined Teva as CEO back in November 2017, the drugmaker was in a world of hurt. It was saddled with debt, costs were high and sales were falling.
Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start of September and, reportedly, arrived for his first day of work at the company yesterday.